[ad_1]
American Pfizer and German Laboratories BioNTech reported on Monday a “90% effective” vaccine against Covid-19, according to preliminary results from an ongoing trial. This partnership between the pharmaceutical giant and the biotechnology firm paves the way for fruitful collaborations between biotech companies and “big pharma”, in particular, virologist Christian Bréchot and economist Frédéric Brizard explained on Europa 1 on Friday.
>> LIVE – Coronavirus: follow the evolution of the situation on Friday 13 November
A “very virtuous” partnership
The latter is delighted with this partnership which he considers “very virtuous”. “Are they [BioNTech] they invent and Pfizer has entered into an intelligent partnership giving them the ability to develop and market, “according to this health specialist. He notes, in parallel, that in this case” it is not the big pharmacy that is the most innovative “but the ‘biotech company.
ESSENTIALS OF CORONAVIRUS
> Covid: where do we get the most contamination? Lessons from an American studio
> Covid vaccine: what are the remaining obstacles to overcome?
> Covid: Should We Worry If Headaches Persist After Recovery?
> When are we in contact? And other questions we ask ourselves every day
> Coronavirus: the 5 mistakes not to make with the mask
According to the OECD, biotechnology brings together “the applications of science and technology …
More information on Europe 1
Source link
